Vertex Pharmaceuticals/VRTX
$445.21
1.03%About Vertex Pharmaceuticals
Ticker
Sector
Trading on
Industry
CEO
Employees
Headquarters
VRTX Metrics
$115B
28.88
$15.42
0.41
-
Price and volume
Financial strength
Management effectiveness
Valuation
Growth
What the Analysts think about VRTX
Analyst Ratings
Price Targets
$445.21
$467.71
VRTX Financial Performance
Income Statement
Q1 24
QoQ growth
$2.7B
6.87%
$1.1B
13.5%
40.86%
6.21%
VRTX Earnings Performance
Earnings per share (EPS)
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
$3.89
$4.08
$4.20
$4.76
-
$3.88
$3.97
$4.10
$4.06
$4.18
0.21%
2.67%
2.37%
17.15%
-
Upcoming events
FAQs
What’s the current market cap for Vertex Pharmaceuticals stock?
What is the P/E ratio for Vertex Pharmaceuticals stock?
Does Vertex Pharmaceuticals stock pay dividends?
No, Vertex Pharmaceuticals (VRTX) stock does not pay dividends to its shareholders as of May 20, 2024.
When is the next Vertex Pharmaceuticals dividend payment date?
Vertex Pharmaceuticals (VRTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Vertex Pharmaceuticals?
Vertex Pharmaceuticals (VRTX) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Vertex Pharmaceuticals stock price target?
The target price for Vertex Pharmaceuticals (VRTX) stock is $467.71, which is 5.05% above the current price of $445.21. This is an average based on projections from 25 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.